Wella responds to P&G offer
This article was originally published in The Rose Sheet
Executive Summary
Procter & Gamble's tender offer for Wella shares is "fair based on all relevant circumstances," Wella's executive board says in May 9 statement. However, the board did not recommend whether shareholders should accept or decline the offer. P&G tendered an offer to buy Wella ordinary shares for $105.7 (€1=$1.15) and preference shares for $74.4 in April (1"The Rose Sheet" May 5, 2003, p. 5). P&G has offered Wella CEO Heiner Gürtler responsibility for the cosmetics and fragrances business Cosmopolitan Cosmetics, the global responsibility for the professional hair care division within P&G and membership in P&G's Global Leadership Council, Wella adds...
You may also be interested in...
P&G Tender Offer Increase Adds $86 Mil. To Wella Price Tag
Procter & Gamble increased its offer for Wella preference shares $3.86 (€1=$1.10) to $71.76 per share in a tender offer launched April 28
Amgen/AstraZeneca’s Tezepelumab Cuts Asthma Exacerbations By 56%
Data presented at AAAI meeting show reduced annualized asthma exacerbation rates across all patient populations, but doctors are unlikely to switch patients served well by existing biologics.
Sarepta’s Next-Generation Drugs Draw Attention Amid ‘Incremental’ Approval
The RNA drug’s accelerated approval brings Sarepta’s exon-skipping market share to nearly 30%.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: